← SynDRA
AR-12
SynDRA canonical compound SYN0026081 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | PDPK1 |
|---|
| Mechanism of action | phosphoinositide dependent kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PDPK1 INHIBITOR
- 3-phosphoinositide dependent protein kinase-1 inhibitor
- phosphoinositide dependent kinase inhibitor
- PDPK1 MODULATOR
Cross-references
Synonyms
- Pdk1 inhibitor ar-12
- OSU-03012
- AR 12
- 2-Amino-N-(4-(5-(phenanthren-2-yl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)phenyl)acetamide
- OSU 03012
- OSU03012
- PDK1 inhibitor AR-12
- OSU-03012 (AR-12)
- UNII-EX3O2Q61UV
- EX3O2Q61UV
- CHEMBL1650595
- 2-amino-N-[4-[5-phenanthren-2-yl-3-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide
- 2-Amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]acetamide
- PubChem22592
- MLS006010170
- SCHEMBL570472
- GTPL8005
- C26H19F3N4O
- EX-A253
- DTXSID50225206
- CHEBI:131196
- MolPort-009-019-120
- RefChem:1062226
- DTXCID10147697
- MFCD12912272
- AR-12 (OSU-03012)
- AR12
- orb1305446
- SCHEMBL30099806
- YULUCECVQOCQFQ-UHFFFAOYSA-N
- HMS3654O21
- HMS3750G15
- BDBM50430630
- NSC756657
- s1106
- AKOS025117573
- CCG-269335
- CS-0151
- NSC-756657
Look up AR-12 in the interactive SynDRA portal →